Cleared Traditional

K181262 - SpineJack Expansion Kit

K181262 is the FDA 510(k) clearance for SpineJack Expansion Kit by Vexim SA. It is a Class 2 Orthopedic device (product code NDN) cleared through the Traditional 510(k) pathway after a 111-day FDA review.

K181262 · Vexim SA · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2018
Decision
111d
Days
Class 2
Risk

K181262 is an FDA 510(k) clearance for the SpineJack Expansion Kit. Classified as Cement, Bone, Vertebroplasty (product code NDN), Class II - Special Controls.

Submitted by Vexim SA (Balma, FR). The FDA issued a Cleared decision on August 30, 2018 after a review of 111 days - within the typical 510(k) review window.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3027 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all Vexim SA devices

Submission Details

510(k) Number K181262 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 11, 2018
Decision Date August 30, 2018
Days to Decision 111 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
11d faster than avg
Panel avg: 122d · This submission: 111d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code NDN Cement, Bone, Vertebroplasty
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3027
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Consultant

Hogan Lovells US LLP
Janice Hogan

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - NDN Cement, Bone, Vertebroplasty

All 44
Devices cleared under the same product code (NDN) and FDA review panel - the closest regulatory comparables to K181262.
V-STRUT Vertebral Implant
K191709 · Hyprevention Sas · Mar 2020
TRACKER Kyphoplasty System
K192335 · GS Medical Co., Ltd. · Dec 2019
VK100 Percutaneous Vertebral Augmentation System
K192403 · Bonwrx, Ltd. · Nov 2019
SpineKure Kyphoplasty System
K172871 · Hanchang Co., Ltd. · May 2018
KYPHON HV-R Bone Cement
K180700 · Medtronic Sofamor Danek USA, Inc. · May 2018
Kyphon Xpede Bone Cement
K163032 · Medtronic, Inc. · Feb 2017